Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Fermenta Biotech Ltd - 506414 - Board Meeting Intimation for Notice Of Board Meeting And Closure Of Trading Window

 Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, June 29, 2021, inter alia: (i) to consider and approve the audited financial results of the Company (standalone and consolidated) for the quarter and financial year ended March 31, 2021; and (ii) to consider and recommend final equity dividend, if any, for the financial year 2020-21.
22-06-2021
Bigul

Fermenta Biotech Ltd - 506414 - Outcome Of Board Meeting

 (i) appointment of Mr. Krishna Datla (DIN: 00003247) as a Whole-time Director of the Company (Key Managerial Personnel), designated as Executive Vice-Chairman, for a period of 3 years commencing from May 9, 2021 to May 8, 2024, subject to members' approval at their ensuing general meeting. (ii) appointment Mr. Prashant Nagre (DIN: 09165447) as an additional director on the Board of Directors of the Company w.e.f. May 6, 2021and (iii) appointment of Mr. Prashant Nagre as (DIN: 09165447) as the Managing Director of the Company (Key Managerial Personnel) for a period of 3 years commencing from May 9, 2021 to May 8, 2024, subject to members' approval at their ensuing general meeting Requisite details of directors in terms of SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 and affirmation pursuant to BSE Circular LIST/COMP/14/2018-19 dated June 20, 2018 are provided in Annexure 1 A copy of the Press Release for the same is attached for your intimation and records
06-05-2021
Bigul

Fermenta Biotech Ltd - 506414 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Pursuant to the provisions of Regulation 74(5) of SEBI (Depositories and Participants), Regulations 2018, for the quarter ended March 31, 2021, we hereby certify that on receipt of securities for dematerialization - a. The securities comprised in the said certificate(s) of security have been listed on the stock exchanges where the earlier securities are listed; b. The said certificate(s) after due verification have been mutilated and cancelled and the name of the depositories have been substituted in the register of members as the registered owner. The above is confirmed based on the certificate received from our Registrar and Transfer Agent - Link Intime India Private Limited, which is enclosed herewith. Kindly take the above on record and oblige.
23-04-2021
Bigul

Fermenta Biotech Ltd - 506414 - Compliance Certificate - Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Period October 01, 2020 To March 31, 2021

 As per the requirement of Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained during the period October 01, 2020 to March 31, 2021 (both days inclusive) by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Private Limited, which is registered as Registrar & Share Transfer Agent in Category-I with the Securities and Exchange Board of India vide Registration Number : INR000004058.
23-04-2021
Bigul

Fermenta Biotech Ltd - 506414 - Compliance Certificate Under Regulation 40(9) Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 - For The Half Year Ended March 31, 2021

 Pursuant to Regulation 40(9) of the Listing Regulations, we are enclosing Certificate dated April 22, 2021 issued by M/s V. N. Deodhar & Co., Company Secretaries, for the half year ended March 31, 2021
22-04-2021
Bigul

Fermenta Biotech Ltd - 506414 - Shareholding for the Period Ended March 31, 2021

 Fermenta Biotech Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here
21-04-2021
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Schedule of Analysts / Institutional Investors meeting over conference call under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting with the Analysts / Institutional Investors over conference call on Tuesday, April 20, 2021 to discuss the investor presentation for February 2021. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company.
19-04-2021
Bigul

Fermenta Biotech Ltd - 506414 - Statement Of Investor Complaints For The Quarter Ended March 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- SRIKANT SHARMADesignation :- Company Secretary and Compliance Officer
07-04-2021
Bigul

Fermenta Biotech Ltd - 506414 - Closure of Trading Window

 Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, Company''s Code of Conduct for Prevention of Insider Trading, and BSE circular no. LIST/COMP/01/2019-20 dated April 2, 2019 regarding intimation for closure of Trading Window, it is hereby notified that the 'Trading Window' (period for trading in Company's securities) will be closed with effect from April 01, 2021 till 48 hours after the declaration of financial results for the quarter and year ended March 31, 2021, as may be approved at the Board Meeting. During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons including Auditors shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company's equity shares, either in their own name or in the name of their immediate relatives. The intimation regarding the Board Meeting date will be made in due course.
26-03-2021
Bigul

Fermenta Biotech Ltd - 506414 - Closure of Trading Window

 Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, Company''s Code of Conduct for Prevention of Insider Trading, and BSE circular no. LIST/COMP/01/2019-20 dated April 2, 2019 regarding intimation for closure of Trading Window, it is hereby notified that the 'Trading Window' (period for trading in Company's securities) will be closed with effect from April 01, 2021 till 48 hours after the declaration of financial results for the quarter and year ended March 31, 2021, as may be approved at the Board Meeting. During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons including Auditors shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company's equity shares, either in their own name or in the name of their immediate relatives. The intimation regarding the Board Meeting date will be made in due course.
26-03-2021
Next Page
Close

Let's Open Free Demat Account